Related Experiment Video
Updated: Mar 31, 2026
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and
Jardin Leleux1, Alexandra Atalis1, Krishnendu Roy1
1The Wallace H. Coulter Dept. of Biomedical Engineering at Georgia Tech and Emory University and The Center for Immunoengineering at Georgia Tech, The Parker H. Petit Institute for Bioengineering and Biosciences Georgia Institute of Technology, Atlanta, GA 30332, United States.
Developing advanced vaccines requires understanding dendritic cell (DC) subsets. Targeting these immune cells offers a sophisticated approach to control immune responses and combat challenging diseases.
Area of Science:
- Immunology
- Vaccinology
- Cell Biology
Background:
- Current vaccines face challenges against evasive pathogens.
- Sophisticated strategies are needed to control vaccine-induced immune responses.
- Dendritic cells (DCs) bridge innate and adaptive immunity, directing immune responses.
Purpose of the Study:
- To review dendritic cell subset biology.
- To discuss immunotherapeutic strategies targeting DCs for vaccine development.
- To enhance vaccine efficacy against complex diseases.
Main Methods:
- Review of current scientific literature on dendritic cell subsets.
- Analysis of immunotherapeutic strategies involving DC targeting.
- Discussion of DC subset functions in lymphoid organs and periphery.
Main Results:
- Dendritic cells comprise diverse subsets with unique immune functions.
- Targeting specific DC subsets can modulate and control immune responses.
- Understanding DC subset interactions is crucial for effective vaccine design.
Conclusions:
- Targeting dendritic cell subsets is a promising strategy for novel vaccine development.
- Further research into DC subset biology will improve vaccine efficacy.
- Advanced immunotherapies leveraging DCs can overcome limitations of current vaccines.
More Related Videos
07:04Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
Published on: September 16, 2018
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Related Concept Videos
01:51Vaccinations
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:21Vaccines
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:23Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
01:20Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...